Primary cutaneous lymphoma associated with Epstein-Barr virus and azathioprine therapy

Clinical and Experimental Dermatology

Volumn 35, Issue 6, 2010, Pages 674-676

  McAleer, M A ^a   D'Arcy, C A ^a   Mulligan, N J ^b   Sheahan, K ^a   Collins, P ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

AGED; ANAMNESIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; EPSTEIN BARR VIRUS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN LYMPHOMA;

AGED; AZATHIOPRINE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; SKIN NEOPLASMS;

EID: 77954316696     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03799.x     Document Type: Letter

References (5)

1. Wallet-Faber N, Bodemer C, Blanche S et al. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children. J Am Acad Dermatol 2008 58: 74 80.
2. Maruani A, Wierzbicka E, Machet MC et al. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis. J Am Acad Dermatol 2007 57: S69 71.
3. Chai C, White WL, Shea CR et al. Epstein-Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol 1999 26: 242 247.
4. Tournade A, D'Incan M, Dubost JJ et al. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. Mayo Clin Proc 2001 76: 845 848.
5. Senff NJ, Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphoma and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2007 157: 1205 1211.